science

TCB-2

TCB-2 is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand TCB-2 rather than just read about it. In short: TCB-2, also known as 2CBCB or 2C-BCB, is a putative psychedelic drug of the phenethylamine, 2C, and benzocyclobutene families related to 2C-B. It is a cyclized phenethylamine and is the derivative of 2C-B in which the β position has been connected to the 6 position by a methylene bridge to form a benzocyclobutene ring system.

Key takeaways

TCB-2 belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect TCB-2 to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of TCB-2 from memory before moving on to harder problems.

Reference excerpt

TCB-2, also known as 2CBCB or 2C-BCB, is a putative psychedelic drug of the phenethylamine, 2C, and benzocyclobutene families related to 2C-B. It is a cyclized phenethylamine and is the derivative of 2C-B in which the β position has been connected to the 6 position by a methylene bridge to form a benzocyclobutene ring system. It is unclear whether TCB-2 produces hallucinogenic effects in humans and its route of administration and properties such as dose and duration are unknown. The drug is a highly potent serotonin receptor agonist, including of the serotonin 5-HT2A receptor among others. TCB-2 produces psychedelic-like effects in animals. It may be among the most potent known serotonin 5-HT2A receptor agonists and psychedelic phenethylamines. TCB-2 is often employed as its more potent and selective enantiomer (R)-TCB-2 in scientific research. TCB-2 was first described in the scientific literature by Thomas McLean and colleagues of the lab of David E. Nichols at Purdue University in 2006. It was encountered as a novel designer drug by 2018, though it appears to be very rare. The drug is not an explicitly controlled substance in the United States and is fully legal for use in scientific research in this country. TCB-2 was suggested as an alternative and replacement of the widely employed DOI for use in research in 2025.

Use and effects TCB-2 does not appear to have been formally tested in humans and its properties and effects are unknown. However, Daniel Trachsel has reported based on anonymous personal communication in 2009 that TCB-2 is psychoactive in the low-milligram range (route unspecified but presumably oral). No additional details were provided, including notably with regard to the nature of the effects. There are also a number of trip reports of TCB-2 on online forums, but such reports are unconfirmed and may not be reliable. In relation to the preceding, it has been said that there are no valid data on TCB-2 in humans.

Interactions

Pharmacology

Pharmacodynamics

TCB-2 acts as a potent agonist of the serotonin 5-HT2A and 5-HT2C receptors. Its affinity (Ki) for the serotonin 5-HT2A receptor has been reported to be 0.75 nM and to be similar to that of 2C-B (Ki = 0.88 nM). The (R)-enantiomer shows 3-fold higher affinity for the serotonin 5-HT2A receptor as well as 2-fold higher activational potency at this receptor. TCB-2 is a biased agonist of the serotonin 5-HT2A receptor, showing 65-fold higher potency in stimulating phosphoinositide turnover than in activating arachidonic acid release. Besides the serotonin 5-HT2 receptors, TCB-2 might importantly stimulate the serotonin 5-HT1A receptor. The comprehensive receptor interactions of TCB-2 have been studied. It is a potent agonist of the serotonin 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT1F, 5-HT2A, 5-HT2B, and 5-HT2C receptors, with the highest activity at the serotonin 5-HT2A receptor. (R)-TCB-2 has been found to substitute for LSD and DOI in rodent drug discrimination tests. It showed similar potency in this regard as LSD and 11- to 13-fold greater potency than DOI, making it one of the most potent known psychedelic drugs in this assay. In contrast to (R)-TCB-2, (S)-TCB-2 was inactive in the test even at a more than 10-fold higher dose. TCB-2 also produces the head-twitch response, another behavioral proxy of psychedelic effects, in rodents. However, in contrast to drug discrimination, the drug required surprisingly high doses to produce the head-twitch response, showing similar potency to that of DOI in this assay. This might be related to TCB-2's biased serotonin 5-HT2A receptor agonism. In addition to its psychedelic-like effects, TCB-2 has been found to produce hyperlocomotion at lower doses and hypolocomotion at higher doses in rodents. The drug produces rapid antidepressant-, anti-anhedonic-, and anxiolytic-like effects in animals. TCB-2 shows anti-inflammatory effects in preclinical research, albeit with lower potency and efficacy than non-cyclized analogues. Unlike other psychedelic phenethylamines, TCB-2 produces some behavioral serotonin syndrome-like effects in rodents. Other animal studies have also been done.

Chemistry

Synthesis The chemical synthesis of TCB-2 has been described. The synthesis of TCB-2 has been described as tedious, such that its manufacture has been prevented from being economical, although it is still available commercially for use in scientific research.

Analogues Analogues of TCB-2 include 2C-B, DOB, β-methyl-2C-B (BMB), tomscaline, 2CB-Ind, jimscaline, LPH-5, 2CBCB-NBOMe (NBOMe-TCB-2), and ZC-B, among others. 2CBCB-NBOMe, the NBOMe derivative of TCB-2, shows 2.7-fold higher affinity for the serotonin 5-HT2A receptor than TCB-2 itself.

History TCB-2 was first described in the scientific literature by Thomas McLean and colleagues of the lab of David E. Nichols at Purdue University in 2006. At the time of its discovery, it was the most potent known phenethylamine psychedelic, with (R)-TCB-2 having similar potency as the better-known LSD, at least on the basis of rodent drug discrimination assays. However, subsequent studies using the head-twitch response found it to be much less potent. TCB-2 was reported to have been encountered as a novel designer drug by 2018, although it appears to be very rare. In late 2025, TCB-2 was suggested as an alternative and replacement of the widely employed DOI for use in research. This was due to DOI being poised to become a restricted Schedule I controlled substance in the United States.

Society and culture

Availability TCB-2 is commercially available for use in scientific research.

Legal status

Canada TCB-2 is not a controlled substance in Canada as of 2025.

United States TCB-2 is not a controlled substance in the United States. However, it could be considered an analogue of 2C-B under the Federal Analogue Act. In any case, as it is not an explicitly controlled substance, there are no restrictions on use of TCB-2 for scientific research purposes.

See also Cyclized phenethylamine Substituted benzocyclobutene 2C (psychedelics)

References

External links TCB-2 (2CBCB) - Isomer Design The Big & Dandy TCB-2 Thread - Bluelight TCB-2 Reports - Erowid Experience Vaults - Erowid

Illustrations

Worked examples

Example 1 — a first encounter with TCB-2

Start with the simplest possible case. Write down what TCB-2 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to TCB-2 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about TCB-2 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of TCB-2

In research: TCB-2 appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses TCB-2 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: TCB-2 is common in secondary-school and first-year university syllabi. It links to neighbouring topics 2C (psychedelics), 5-HT1A agonists, 5-HT1B agonists, so understanding it makes those chapters shorter.
In everyday life: Look for TCB-2 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “TCB-2” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study TCB-2 in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what TCB-2 means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain TCB-2 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is TCB-2 in simple terms?

Why does TCB-2 matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study TCB-2?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on TCB-2.